Q3 2016 13F Holders as of 9/30/2016
-
Type / Class
-
Equity / COM
-
Number of holders
-
366
-
Total 13F shares, excl. options
-
90M
-
Shares change
-
+2.37M
-
Total reported value, excl. options
-
$5.83B
-
Value change
-
+$155M
-
Put/Call ratio
-
1.4
-
Number of buys
-
167
-
Number of sells
-
-156
-
Price
-
$64.79
Significant Holders of RESMED INC - COM (RMD) as of Q3 2016
411 filings reported holding RMD - RESMED INC - COM as of Q3 2016.
RESMED INC - COM (RMD) has 366 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 90M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (10.7M shares), Capital World Investors (8.5M shares), BlackRock Fund Advisors (6.14M shares), BAILLIE GIFFORD & CO (5.15M shares), STATE STREET CORP (4.58M shares), BlackRock Institutional Trust Company, N.A. (4.34M shares), FMR LLC (4.22M shares), Bank of New York Mellon Corp (2.39M shares), COMMONWEALTH BANK OF AUSTRALIA (1.99M shares), and SCHRODER INVESTMENT MANAGEMENT GROUP (1.45M shares).
This table shows the top 366 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.